Almost 40% of the county’s 2024 homicides were from instances of IPV.
Spotlight on VPM Original Content
Virginia News
NPR News
Virginia News
-
Until recently, the VA was adding thousands of employees to try to keep up with increased demand for veterans' medical care.
-
The state court ruled deputies’ names and salaries must be disclosed.
-
The money deals with flooding and sea level rise, and could help cope with electricity demand.
-
Changes don’t necessarily mean staff will be laid off.
-
Emissions’ social costs can help guide investments.
-
The track’s new operator aims to reopen as soon as next year.
NPR News
-
Three key committees are putting pen to paper on Trump's "big beautiful bill." But lawmakers are at odds over policies with far-reaching impacts on Americans' wallets and, for many, their health care.
-
Although business owners welcomed a temporary deal with China to slash tariffs, there's still considerable uncertainty about what happens next.
-
President Trump made the announcement at an investment conference in Saudi Arabia. He is also heading to Qatar and the UAE on a trip focused on big-dollar deals.
-
The Episcopal Church says it will not assist with the resettlement of white South Africans and will end its government partnership to support refugees. The church's presiding bishop, Sean Rowe, explains why.
-
A broad coalition of addiction experts wants Congress to maintain healthcare funding for the nation's response to fentanyl and other street drugs.
Arts & Culture
- Tara Roberts helps scuba divers uncover slave shipwrecks
- New Burying Ground honors enslaved labor at University of Richmond
- Museums, libraries and cultural groups grapple with federal humanities cuts
- ‘Idleness and boredom’: Virginia juvenile justice system strained by staffing shortages
Listen to VPM
- VPM Daily Newscast: Richmond City Council finalizes $3 billion FY26 budget
- Guest conductor Michael Repper leads the Richmond Symphony in Berlioz's Symphonie Fantastique
- VPM Daily Newscast: ‘Catalyst’ UVA Manning Institute for Biotechnology
- Interview: Keep finds the new normal